Mann-Whitney t-test. Correlations between cytokines, proteases, and celllineage markers were detected using Spearman's correlation test. Results: SM Il-15 mRNA and SF protein levels were detectable in all early OA patients (18 SM and 11 SF), and in most end-stage patients as well (11/13 SM and 9/10 SF); furthermore protein levels were elevated in the early knee OA patients when compared to end-stage (p = 0.0004). In contrast, SM Il-21 mRNA levels were detectable in 11/18 early OA patients and in all end-stage patients, while SF protein levels were measurable in 7/10 end-stage and 5/9 early OA patients. Il-21 mRNA and protein levels did not differ in the two patient groups. In early OA patients, Il-15 transcript levels within the tissue were associated with CD8 transcript levels (r = 0.508, p = 0.04), and Il-21 mRNA levels correlated with CD19 (r = 0.746, p = 0.0009) and CD56 (r = 0.742, p = 0.0015) expression, consistent with the known effects of these cytokines on specific lymphocyte subsets. Il-15 transcript levels were associated with both Il-21 mRNA (r = 0.445, ns trend p = 0.08) and protein levels (r = 0.783, p = 0.017), suggesting coordinate regulation of these two cytokines. Finally, increasing SF Il-15 was positively associated with both total (r = 0.582, p = 0.023) and active (r = 0.576, p = 0.025) SF MMP-1 concentration.
ACTIVITY AND EXPRESSION OF HYALURONIDASES

ASSOCIATED WITH HYALURONAN SYNTHASES EXPRESSION AND CHANGE OF MOLECULAR WEIGHT OF HYALURONAN IN THE JOINT FLUID
M. Uzuki 1 , Y. Sasaki 1 , S. Tokunaga 1 , A. Kamataki 1 , K. Nomi 2 , H. Kitagawa 2 , J. Kaiyama 3 , T. Sawai 1 . 1 Iwate Medical University, School of Medicine, Morioka, Iwate, JAPAN, 2 Denki Kagaku Kogyo Co, LTD, Machida, JAPAN, 3 Iwate Prefectural Isawa Hospital, Ohsyu, Iwate, JAPAN Purpose: Hyaluronidase (Hyal) and hyaluronic acid synthase (HAS) were cloned in human recently. HAS-1 and HAS-2 synthesize high molecular weight (2×10 6 Da) hyaluronic acid (HA), while HAS-3 synthesizes low molecular weight one (2×10 5 Da). It has been obscure why the molecular weight of HA in synovial fluid (SF) decreases in the patients with rheumatoid arthritis (RA). In order to study the relationship between the expression patterns of Hyals, HASs, Hyal activity and HA molecular weight in SF, we examined the expression of these enzymes in the articular tissue of patients with RA. Methods: Synovial tissues/fluids were obtained from 58 patients with RA at various stage of inflammation, 27 patients with osteoarthritis and 6 with trauma. We studied Hyals (Hyal-1, -2, -3) and HASs (HAS-1, -2, -3) expression by using mRNA in situ hybridization analysis and immunohistochemistry. In addition, we investigated Hyal activity in SF samples by HA substrate gel enzyme zymography. Then we examined HA molecular weight in SF by HPLC.
Hyaluronidase activity and molecular weight of HA in SF.
Results: Hyals were detected in synoviocytes. The number of positive cells of Hyals was higher in RA active stage than in non-inflamed control patients. Utilizing Hyal enzyme zymography, the enzyme activity of Hyal in synovial fluid was higher in the active stage of RA than in the fibrotic one. There was negative correlation between Hyal activity and molecular weight of HA in SF (r = −0.55, p < 0.005) (Fig) . The enzyme activity of Hyal in SF was positively correlated with the number of positive cells of Hyals mRNA in synovial tissues. HAS-1, -2 were detected in synoviocytes. On the other hand, HAS-3 was detected in synoviocytes and inflammatory cells. The number of positive cells of HAS-1 and HAS-2 was lower in RA advanced stage although that of HAS-3 positive cells reached maximum level in the active inflammatory stage. Moreover, the number of HAS-3 positive cells was negatively correlated with the HA molecular weight in synovial fluid (r = −0.51, p < 0.005) and positively correlated with histologically defined local inflammatory activity in RA (r = 0.563, p < 0.005).
Conclusions:
The results suggest that HA may be actively synthesized by HAS-1 or HAS-2 in early stage of RA and become to smaller size by HAS-3 products and degeneration by Hyals in inflammatory stage of RA. The number and distribution of Hyals and HASs can be affected by synovial inflammation. Purpose: There are many in vitro systems for studying cartilage degeneration, but most do not model interactions between the various cell types in a joint. We developed an in vitro model of cartilage degradation using cells that are representative of those found in osteoarthritic joints. Our goal was to generate a compositional profile similar to that found in OA synovial fluid (as distinct from that in inflammatory conditions, such as rheumatoid arthritis) that would lead to cartilage degeneration. Methods: Synovial fibroblasts (Type B cells), isolated from a 68-yearold normal donor, were cultured overnight at 2.5×10 4 /cm 2 in 24-well cell culture inserts in medium containing DMEM with 10% FBS and 50 ug/ml Gentamicin. The next day, premonocytic U937 cells, representing synovial Type A cells, were added to the insert at 1.0×10 5 /cm 2 . The two cell types were cultured together for 3 days, promoting differentiation of the U937 cells into monocytes. After 3 days, medium was changed to be serum-free and 6 mm full-thickness cartilage discs isolated from 6-month-old calves were added to the wells containing the cell-laden inserts. To stimulate the system with potential mediators of OA, cultures were treated with the N-terminal 30 kDa fibronectin fragment (Fn-f, 0.8 mM) or urokinase-type plasminogen activator (uPa, 15 nM). Il-1b treatment (5 ng/mL) was used as a positive control. To study the specific effects of Il-1 on stimulated cocultures, some samples were preincubated with 1.4 nM Il-1ra for 4 hours before stimulation. After 7 days, medium was assessed for sGAG content (DMMB), and for Il-1b, Il-1ra, Il-10, Il-6, Il-8, RANTES, TNFa and MMP-1, -3, and -13 (Luminex xMAP). GAG was also determined in cartilage discs (DMMB, and Safranin O histology).
GENERATION OF OSTEOARTHRITIS-LIKE
